Laekna Limited

This study tested whether adding a new drug called afuresertib to standard chemotherapy (paclitaxel) works better for women with platinum-resistant ovarian cancer. About 150 participants were randomly assigned to receive either the combination or chemotherapy alone. The main goal…

This study tested a new three-drug combination (afuresertib, sintilimab, and chemotherapy) for people with advanced solid tumors that had stopped responding to prior immunotherapy. The goal was to find a safe, effective dose and see if this combination could help control cancer g…

This was an early-stage study to check the safety of a new drug called LAE102 and see how the body processes it. It involved 32 healthy women who had gone through menopause. Participants received a single dose of either the drug or a placebo, and researchers monitored them for si…